Samrat Pharmachem Ltd
BSE:530125
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IN |
|
Samrat Pharmachem Ltd
BSE:530125
|
720.8m INR |
Loading...
|
|
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
89.6B USD |
Loading...
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
82.2B USD |
Loading...
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
9.6T JPY |
Loading...
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
272.8B CNY |
Loading...
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
28.6B CHF |
Loading...
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
28.3B USD |
Loading...
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK |
Loading...
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR |
Loading...
|
|
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR |
Loading...
|
|
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
18.6B EUR |
Loading...
|
Market Distribution
| Min | -305 007.7% |
| 30th Percentile | 2.1% |
| Median | 5.8% |
| 70th Percentile | 11.6% |
| Max | 1 221 633.3% |
Other Profitability Ratios
Samrat Pharmachem Ltd
Glance View
Samrat Pharmachem Ltd. engages in the manufacturing manufacturing and selling chemicals. The company is headquartered in Mumbai, Maharashtra. The firm is a supplier of iodine derivatives to the Indian and foreign market. The Company’s products include 3-5-Di Iodosalicylic Acid, Ammonium Iodide, Calcium Iodide, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodic Acid, Iodine, Iodine Monochloride, Iodoquinol, Lithium Iodide, Methyl Iodide, N-Iodo Succcinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate, Sodium Selenite, Tetra Butyl Ammonium Iodide, and Tri Methyl Sulphoxonium Iodide. The company serves various industries, such as agrochemical, animal feed, chemicals, food, pharmaceutical, printing, and textile. The firm exports its products to various countries, including United States, Europe, Africa, Asia, and Middle East.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Samrat Pharmachem Ltd is 0.5%, which is below its 3-year median of 1.9%.
Over the last 3 years, Samrat Pharmachem Ltd’s Net Margin has decreased from 10.5% to 0.5%. During this period, it reached a low of 0% on Dec 31, 2023 and a high of 10.5% on Aug 30, 2022.
